WST
West Pharmaceutical Services, Inc.
Stock
$364.98−0.03 (−0.01%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $24M
- YoY, 2025
- +27.3%
- 5-year CAGR
- −6.9%
- 10-year CAGR
- −2.2%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $24M | +27.3% |
| 2024 | $19M | −19.7% |
| 2023 | $23M | −1.7% |
| 2022 | $24M | −36.8% |
| 2021 | $38M | +10.3% |
| 2020 | $34M | +39.3% |
| 2019 | $24M | +61.6% |
| 2018 | $15M | −6.2% |
| 2017 | $16M | −17.4% |
| 2016 | $20M | −34.1% |
| 2015 | $30M | +59.1% |
| 2014 | $19M | −12.3% |
| 2013 | $21M | +36.8% |
| 2012 | $16M | +84.5% |
| 2011 | $8.4M | +7.7% |
| 2010 | $7.8M | +4.0% |
| 2009 | $7.5M | +17.2% |
| 2008 | $6.4M | — |